MXPA03001207A - Composicion farmaceutica que comprende un compuesto indol condensado. - Google Patents

Composicion farmaceutica que comprende un compuesto indol condensado.

Info

Publication number
MXPA03001207A
MXPA03001207A MXPA03001207A MXPA03001207A MXPA03001207A MX PA03001207 A MXPA03001207 A MX PA03001207A MX PA03001207 A MXPA03001207 A MX PA03001207A MX PA03001207 A MXPA03001207 A MX PA03001207A MX PA03001207 A MXPA03001207 A MX PA03001207A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
indole compound
condensed indole
condensed
pharmaceutically acceptable
Prior art date
Application number
MXPA03001207A
Other languages
English (en)
Inventor
Seona Thomson
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0019524A external-priority patent/GB0019524D0/en
Priority claimed from GB0118919A external-priority patent/GB0118919D0/en
Priority claimed from GB0119022A external-priority patent/GB0119022D0/en
Priority claimed from PCT/GB2001/003544 external-priority patent/WO2002011766A2/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Priority claimed from PCT/GB2001/003590 external-priority patent/WO2002011733A1/en
Publication of MXPA03001207A publication Critical patent/MXPA03001207A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Una composicion farmaceutica comprende N -[(1-nbutil-4- piperidinil) metil]-3, 4-dihidro-2H-[1,3] oxazino[3, 2-a]indol- 10-carboxamida (SB 207266) o una sal farmaceuticamente aceptable de la misma en combinacion con uno o mas portadores farmaceuticamente aceptables, en donde al menos una parte de SB 207266 o sal de la misma se encuentran en forma granulada;. preferiblemente, tambien estan presentes una sustancia de relleno y/o aglutinante.
MXPA03001207A 2000-08-08 2001-08-08 Composicion farmaceutica que comprende un compuesto indol condensado. MXPA03001207A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0019524A GB0019524D0 (en) 2000-08-08 2000-08-08 Novel use
GB0118919A GB0118919D0 (en) 2001-08-02 2001-08-02 Novel use
GB0119022A GB0119022D0 (en) 2001-08-03 2001-08-03 Novel use
PCT/GB2001/003544 WO2002011766A2 (en) 2000-08-07 2001-08-07 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
PCT/GB2001/003590 WO2002011733A1 (en) 2000-08-08 2001-08-08 Pharmaceutical composition comprising condensed indole compound

Publications (1)

Publication Number Publication Date
MXPA03001207A true MXPA03001207A (es) 2004-08-12

Family

ID=27255838

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03001207A MXPA03001207A (es) 2000-08-08 2001-08-08 Composicion farmaceutica que comprende un compuesto indol condensado.

Country Status (12)

Country Link
US (3) US20030032640A1 (es)
EP (2) EP1872785A1 (es)
JP (1) JP2008247915A (es)
KR (1) KR100896563B1 (es)
CN (2) CN1268340C (es)
AT (1) ATE374027T1 (es)
BR (1) BR0113169A (es)
CY (1) CY1107836T1 (es)
HK (1) HK1056998A1 (es)
MX (1) MXPA03001207A (es)
NZ (1) NZ535261A (es)
PT (1) PT1313481E (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004505930A (ja) * 2000-08-07 2004-02-26 ラボラトワール・グラクソスミスクライン・ソシエテ・パール・アクシオン・シンプリフィエ 心房細動の予防または治療のための薬物の製造における５ｈｔ４受容体アンタゴニストの使用
JP2005523276A (ja) * 2002-02-14 2005-08-04 グラクソ　グループ　リミテッド Ｎ−［（１−ｎ−ブチル−４−ピペリジニル）メチル］−３，４−ジヒドロ−２ｈ−［１，３］オキサジノ［３，２−ａ］インドール−１０−カルボキシアミド（ｓｂ２０７２６６）またはその塩および乾燥造粒操作を含む方法
GB0211230D0 (en) * 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
JP5637624B2 (ja) * 2009-02-12 2014-12-10 富士化学工業株式会社 崩壊性粒子組成物及びそれを用いた速崩壊性圧縮成型物
TW201129386A (en) 2009-11-05 2011-09-01 Fmc Corp Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
EP3007680B1 (en) * 2013-06-14 2020-02-19 CONARIS research institute AG Extended release nicotinamide formulation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3134719A (en) * 1962-04-05 1964-05-26 American Cyanamid Co Calcium phosphates in tablet compressing
US5066441A (en) * 1980-12-12 1991-11-19 Rhone-Poulenc Basic Chemicals Co. Process for compacting a calcium phosphate composition
US4597969A (en) * 1982-04-05 1986-07-01 Merck Sharp & Dohme Stabilization of unstable drugs or food supplements
DE3332830A1 (de) * 1982-09-16 1984-03-22 The Upjohn Co., 49001 Kalamazoo, Mich. Verwendung von benzodiazepinen zur bekaempfung oder bei der behandlung von panikzustaenden
US4569852A (en) * 1983-08-23 1986-02-11 Warner-Lambert Company Maintenance of flavor intensity in pressed tablets
US4713245A (en) * 1984-06-04 1987-12-15 Mitsui Toatsu Chemicals, Incorporated Granule containing physiologically-active substance, method for preparing same and use thereof
US5055307A (en) * 1988-12-29 1991-10-08 Asahi Kagaku Kogyo Kabushiki Kaisha Slow release drug delivery granules and process for production thereof
US5852014A (en) * 1992-03-12 1998-12-22 Smithkline Beecham P.L.C. Condensed indole derivatives as 5HT4 -receptor antagonists
HU219121B (hu) 1992-03-12 2001-02-28 Smithkline Beecham Plc. Kondenzált indolszármazékok, eljárás előállításukra és ezeket tartalmazó 5-HT4-receptor antagonista hatású gyógyászati készítmények
US5998409A (en) * 1992-03-12 1999-12-07 Smithkline Beecham Plc Condensed indole derivatives as 5HT4 -receptor antagonists
DE4418837A1 (de) * 1994-05-30 1995-12-07 Bayer Ag Thermisches Granulierverfahren
FR2740357B1 (fr) * 1995-10-25 1997-11-28 Rhone Poulenc Chimie Granules redispersables dans l'eau comprenant une matiere active sous forme liquide et un tensio-actif non ionique du type alcoxyles
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
US6660298B1 (en) * 2000-07-27 2003-12-09 Pentech Pharmaceuticals, Inc. Paroxetine tablets and capsules

Also Published As

Publication number Publication date
KR100896563B1 (ko) 2009-05-07
PT1313481E (pt) 2008-01-02
EP1872785A1 (en) 2008-01-02
JP2008247915A (ja) 2008-10-16
NZ535261A (en) 2004-12-24
US20050148582A1 (en) 2005-07-07
CN1268340C (zh) 2006-08-09
KR20030023745A (ko) 2003-03-19
EP1867333A1 (en) 2007-12-19
US20030032640A1 (en) 2003-02-13
CY1107836T1 (el) 2013-06-19
ATE374027T1 (de) 2007-10-15
CN1679583A (zh) 2005-10-12
BR0113169A (pt) 2003-07-15
CN1458845A (zh) 2003-11-26
US20060057218A1 (en) 2006-03-16
HK1056998A1 (en) 2004-03-12

Similar Documents

Publication Publication Date Title
CA2263404A1 (en) Pharmaceutical composition comprising coenzyme q10
ZA9811759B (en) Novel indole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them.
IL172695A0 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
CA2339765A1 (en) Compounds and compositions for delivering active agents
ZA979220B (en) New oxadiazoles, processes for their preparation and their use as pharmaceutical compositions.
HUP0101461A3 (en) Novel pyridazine derivatives and drugs containing the same as the active ingredient
IL145013A0 (en) Tricyclic compounds, processes for the preparation thereof and pharmaceutical compositions containing the same
HK1037329A1 (en) Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
AU7962200A (en) Novel indole derivatives and drugs containing the same as the active ingredient
HUP9901590A3 (en) Substituted aza- and diazacycloheptane and cyclooctane derivatives, use thereof, pharmaceutical compositions containing these compounds
ZA9911B (en) 2,3-substituted indole compounds as anti-inflammatory and analgesic agents.
CA2347195A1 (en) Oral pharmaceutical compositions containing buprenorphin
HK1036974A1 (en) Indole derivatives and medicinal compositions containing the same.
ZA200110150B (en) Streptogramin derivatives, preparation and compositions containing them.
AU5965399A (en) Pharmaceutically active composition
MXPA03001207A (es) Composicion farmaceutica que comprende un compuesto indol condensado.
IL121969A (en) 10,13,15-trioxatricyclo¬9.2.1.1.9.6¾-pentadecanone derivatives their preparation and pharmaceutical compositions containing these compounds
ZA991546B (en) Streptogramin derivatives, their preparation and compositions containing them.
AU1650501A (en) 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
AU1054500A (en) N-substituted (3,6-dihydro)-2h-1,2-oxazine derivatives, their preparation and their use as selective mglur1 antagonists
AU3076600A (en) 3,7-disubstituted indole derivatives and medicinal compositions containing the same
HK1046284A1 (en) Polymorphs of crystalline azabicyclo(2,2,2)octan-3-aminecitrate and their pharmaceutical compositions.
ZA99678B (en) 11-Qcetyl-12, 13-dioxabicyclo[8.2.1]-tridecenone derivatives, processes for the preparation thereof and medicaments containing these compounds.
AU1556601A (en) 1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient
IL135168A0 (en) Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors

Legal Events

Date Code Title Description
GB Transfer or rights
GD Licence granted
FG Grant or registration